🇺🇸 FDA
Patent

US 10071081

Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 10071081 (Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use) held by PTC THERAPEUTICS, INC. expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545